With D.C. drug pricing negotiations still up in the air, the ‘endgame’ could…

via With Democrats in Washington debating the specifics of the president’s infrastructure program, the pharmaceutical industry may be able to squeak out a much-desired drug pricing win. As the negotiations unfold, Politico reports that the party leadership may have to abandon its proposal to have Medicare negotiate drug prices.

Read the source article at Cafepharma
2021-10-06 20:32:00